Home 2018-02-15T18:20:17+00:00
Loading...

The COLOSSUS Project

Colorectal cancer is the third most common cancer in Europe. COLOSSUS is an EU-funded H2020 project that aims to provide new and more effective ways to classify patients with a specific type of colorectal cancer (microsatellite stable RAS mutant metastatic colorectal cancer or MSS RAS mt mCRC) and to develop better treatments for them. Our ultimate goal is to deliver a personalised medicine approach for patients with MSS RAS mt mCRC that is currently not available.

For more details about this innovative project and our aims see here.

Project Partners

The COLOSSUS Project brings together a multidisciplinary team of 14 different partners from 8 different countries.

Latest News

Dr Rodrigo Dienstmann, VHIO presents COLOSSUS at the AACR

October 3rd, 2018|

Dr Rodrigo Dienstmann of Vall d'Hebron University Hospital, Barcelona, Spain presented COLOSSUS at the American Association for Cancer Research (AACR) Intestinal Stem Cells and Colon Cancer: Biology to Therapy conference. The four-day meeting ran from [...]

Darran O’ Connor, RCSI presents COLOSSUS findings at 2018 ASCO

September 28th, 2018|

A study: 'SATB2 loss and the immune milieu of colorectal cancer (CRC)'  was presented by Dr Darran O' Connor, a cancer biologist at the Royal College of Surgeons Ireland at the Gastrointestinal (Colorectal) Cancer session at the [...]

VIEW NEWS